134 related articles for article (PubMed ID: 37946468)
1. Long-term effects of Qingfei Paidu decoction in patients with coronavirus disease 2019 acute pneumonia after treatment: a protocol for systematic review and Meta-analysis.
Rong F; Haoyu HE; Tao T; Hanjin C
J Tradit Chin Med; 2023 Oct; 43(6):1068-1071. PubMed ID: 37946468
[TBL] [Abstract][Full Text] [Related]
2. Qingfei Paidu decoction for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials.
Zhang Y; Xie H; Li Y; Li T; Yuan H; Fu X; Xie C
Medicine (Baltimore); 2020 Sep; 99(36):e22040. PubMed ID: 32899063
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis.
Li Y; Liu X; Guo L; Li J; Zhong D; Zhang Y; Clarke M; Jin R
Syst Rev; 2020 Apr; 9(1):75. PubMed ID: 32268923
[TBL] [Abstract][Full Text] [Related]
4. Melatonin effects on sleep quality of COVID-19 patients: a protocol for systematic review and meta-analysis of randomised controlled trials with trial sequential analysis.
Zhang JJ; Sun R; Guo S; Zhang H
BMJ Open; 2023 Jun; 13(6):e068345. PubMed ID: 37349103
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of Qingfei Paidu decoction combined with antiviral drugs in the treatment of corona virus disease 2019: A protocol for systematic review and meta analysis.
Gao K; Song YP; Chen H; Zhao LT; Ma L
Medicine (Baltimore); 2020 May; 99(22):e20489. PubMed ID: 32481460
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials.
Arab-Zozani M; Hassanipour S; Ghoddoosi-Nejad D
BMJ Open; 2020 Jul; 10(7):e039730. PubMed ID: 32737100
[TBL] [Abstract][Full Text] [Related]
8. Effect of febuxostat on blood pressure in hyperuricemic patients: A protocol for a systematic review and meta-analysis.
Yao J; Shi X; Fan S; Gao Y; Hu H; Wang P; Chen Q
Medicine (Baltimore); 2020 Jun; 99(24):e20673. PubMed ID: 32541512
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis.
Yao J; Gong X; Shi X; Fan S; Chen J; Chen Q
Medicine (Baltimore); 2020 Jun; 99(24):e20674. PubMed ID: 32541513
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.
Wang Q; Zhu H; Li M; Liu Y; Lai H; Yang Q; Cao X; Ge L
Front Pharmacol; 2021; 12():688857. PubMed ID: 34456720
[No Abstract] [Full Text] [Related]
11. Systematic review and meta-analysis of the incidence and prevalence and 30-year trend of inflammatory bowel diseases in Asia: a study protocol.
Safarpour AR; Mehrabi M; Keshtkar A; Edjtehadi F; Bagheri Lankarani K
BMJ Open; 2019 Nov; 9(11):e031854. PubMed ID: 31748306
[TBL] [Abstract][Full Text] [Related]
12. Comparison of telecardiac rehabilitation with centre-based cardiac rehabilitation and usual care: a protocol for systematic review including a meta-analysis.
Bashir Z; Shahab A; Imran H
Open Heart; 2022 Aug; 9(2):. PubMed ID: 35961694
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review.
Li G; Xu Y; Yang YT; Liu PF
BMJ Open; 2020 Jul; 10(7):e040517. PubMed ID: 32641369
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of
Yan H; Zou Y; Zou C
Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):616-623. PubMed ID: 32897211
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease 2019 (COVID-19) related cytopenia: A protocol for systematic review and meta-analysis.
Li Y; Weng Q; Huang X; Xie Y; Chen C; Qian S
Medicine (Baltimore); 2020 Sep; 99(36):e22033. PubMed ID: 32899059
[TBL] [Abstract][Full Text] [Related]
16. The burden, admission, and outcome of COVID-19 in Africa: protocol for a systematic review and meta-analysis.
Tadesse DB; Gebremeskel GG; Asefa GG; Abay M; Demoz GT
Emerg Microbes Infect; 2020 Dec; 9(1):1372-1378. PubMed ID: 32538295
[No Abstract] [Full Text] [Related]
17. Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study.
Yang R; Liu H; Bai C; Wang Y; Zhang X; Guo R; Wu S; Wang J; Leung E; Chang H; Li P; Liu T; Wang Y
Pharmacol Res; 2020 Jul; 157():104820. PubMed ID: 32360484
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Gram-negative bacteria in ventilator-associated pneumonia in neonatal intensive care units: a systematic review and meta-analysis protocol.
Erfani Y; Rasti A; Janani L
BMJ Open; 2016 Oct; 6(10):e012298. PubMed ID: 27729350
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of mass testing for control of COVID-19: a systematic review protocol.
Lopes-Júnior LC; Bomfim E; Silveira DSCD; Pessanha RM; Schuab SIPC; Lima RAG
BMJ Open; 2020 Aug; 10(8):e040413. PubMed ID: 32847926
[TBL] [Abstract][Full Text] [Related]
20. Protection effects of mice liver and lung injury induced by coronavirus infection of Qingfei Paidu decoction involve inhibition of the NLRP3 signaling pathway.
Huang W; Chen X; Yin M; Li J; Luo M; Ai Y; Xie L; Li W; Liu Y; Xie X; Chen Y; Zhang X; He J
J Ethnopharmacol; 2024 Mar; 321():117512. PubMed ID: 38040130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
